CClinicalTrials.gg
CompletedNCT07050719Updated Dec 10, 2025

Can Atelectasis Be Prevented With Oxygen Reserve Index (ORI) Monitoring?

An interventional study of Peripheral Oxygen Saturation (SpO₂) Group and Peripheral Oxygen Saturation and Oxygen Reserve Index (SpO₂-ORI) Group in Atelectasis, Lung Ultrasonography Score and Hyperoxia, sponsored by Antalya Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-12-10.

Sponsored by Antalya Training and Research Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This single-center randomized controlled trial aims to evaluate whether intraoperative monitoring using the Oxygen Reserve Index (ORI) reduces the incidence of postoperative atelectasis, as assessed by lung ultrasound (LUS), in adult patients undergoing elective robotic surgery under general anesthesia.

Read the detailed description

Postoperative atelectasis is observed in 60-90% of patients undergoing general anesthesia. Factors such as high inspired oxygen concentration, muscle relaxation, and reduced functional residual capacity contribute to its development through mechanisms like absorption atelectasis. The persistence of atelectasis increases the risk of pneumonia, hypoxia, prolonged hospital stay, healthcare costs, and mortality. Despite the well-known pathophysiology, the optimal intraoperative fraction of inspired oxygen (FiO₂) remains unclear.

The Oxygen Reserve Index (ORI) is a non-invasive, continuous parameter that reflects the oxygen reserve within the moderate hyperoxia range (100-200 mmHg). It may facilitate individualized FiO₂ titration to avoid hyperoxia-related atelectasis. Lung ultrasound (LUS) is a reliable, radiation-free bedside tool for detecting atelectasis.

This study hypothesizes that ORI-guided oxygen therapy will reduce the incidence of postoperative atelectasis compared to standard Peripheral Capillary Oxygen Saturation (SpO₂)-guided therapy.

02

Conditions studied

  • Atelectasis
  • Lung Ultrasonography Score
  • Hyperoxia

Keywords

  • Atelectasis
  • ORI
  • robotic surgery
  • lung ultrasound score
  • hyperoxia
03

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiologists Physical Status Classification System (ASA) physical status I-III
  • Elective robotic surgery under general anesthesia
  • Surgery duration >2 hours
  • Requires invasive arterial cannulation
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • ASA IV or higher
  • Room air SpO₂ \<92%
  • Chronic pulmonary disease
  • Hemoglobinopathy
  • Pregnancy
  • Refusal to participate
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
58 participants (actual)

Study arms

  • Active comparator
    Peripheral Oxygen Saturation (SpO₂) Group

    FiO₂ adjusted based on pulse oximetry to maintain SpO₂ ≥98%

    Procedure: Peripheral Oxygen Saturation (SpO₂) Group

  • Active comparator
    Peripheral Oxygen Saturation and Oxygen Reserve Index (SpO₂-ORI) Group

    FiO₂ adjusted using both SpO₂ and ORI to maintain ORI between 0-0.3

    Procedure: Peripheral Oxygen Saturation and Oxygen Reserve Index (SpO₂-ORI) Group

Interventions

  • ProcedurePeripheral Oxygen Saturation (SpO₂) Group

    FiO₂ adjusted based on pulse oximetry to maintain SpO₂ ≥98%

  • ProcedurePeripheral Oxygen Saturation and Oxygen Reserve Index (SpO₂-ORI) Group

    FiO₂ adjusted using both SpO₂ and ORI to maintain ORI between 0-0.3

05

What researchers measure

Primary outcomes

  1. Postoperative LUS score at 30 min

    Lung ultrasound (LUS) measurements will be performed by an anesthesiologist blinded to the study groups, who is experienced in lung ultrasonography with at least 100 prior examinations. LUS will be performed and recorded 30 minutes before surgery while patients are in the supine position, using a linear probe (6-12 MHz). The total LUS score will be calculated as the sum of the scores for the 12 quadrants of each hemithorax (range: 0-36). Higher scores will indicate more severe loss of aeration. Loss of aeration will be scored as follows: * 0: Presence of A-lines or fewer than two B-lines * 1: Three or more well-defined B-lines * 2: Presence of multiple coalescent B-lines * 3: Presence of lung consolidation characterized by dynamic air bronchograms

    Time frame: At 30 minutes following tracheal extubation at the end of surgery

Secondary outcomes

  1. Preoperative LUS score

    Lung ultrasound (LUS) measurements will be performed by an anesthesiologist blinded to the study groups, who is experienced in lung ultrasonography with at least 100 prior examinations. LUS will be performed and recorded 30 minutes before surgery while patients are in the supine position, using a linear probe (6-12 MHz). The total LUS score will be calculated as the sum of the scores for the 12 quadrants of each hemithorax (range: 0-36). Higher scores will indicate more severe loss of aeration. Loss of aeration will be scored as follows: • 0: Presence of A-lines or fewer than two B-lines • 1: Three or more well-defined B-lines • 2: Presence of multiple coalescent B-lines • 3: Presence of lung consolidation characterized by dynamic air bronchograms

    Time frame: 30 minutes prior to patient transfer to the operating room

  2. Intraoperative arterial partial pressure of oxygen (PaO₂)

    Arterial blood samples will be collected intraoperatively at baseline (immediately before skin incision) and at the 1st, 2nd, and 3rd hour to measure the partial pressure of oxygen (PaO₂).

    Time frame: At baseline (immediately before incision), and at 1st, 2nd, and 3rd hour intraoperatively

  3. Intraoperative fraction of inspired oxygen (FiO₂)

    The fraction of inspired oxygen administered to the patient will be recorded at baseline (immediately before skin incision) and hourly at the 1st, 2nd, and 3rd hour during surgery.

    Time frame: At baseline (immediately before incision), and at 1st, 2nd, and 3rd hour intraoperatively

  4. Intraoperative Oxygen Reserve Index (ORI)

    Continuous monitoring of the Oxygen Reserve Index (ORI) will be performed, and values will be documented at baseline (immediately before skin incision) and at 1st, 2nd, and 3rd hour intraoperatively.Intraoperative Oxygen Reserve Index (ORI) will be measured. ORI is a unitless index ranging from 0.00 to 1.00, with higher values indicating a greater oxygen reserve.

    Time frame: At baseline (immediately before incision), and at 1st, 2nd, and 3rd hour intraoperatively

  5. Number of episodes with severe hyperoxia (PaO₂ > 200 mmHg)

    The number of severe hyperoxia episodes, defined as PaO₂ levels exceeding 200 mmHg, will be recorded at baseline (immediately before skin incision) and at the 1st, 2nd, and 3rd hour during surgery.Each time point will be evaluated independently, and the number of measurements exceeding 200 mmHg will be counted.This is a binary threshold-based event count, not a continuous scale; thus, no scoring system or scale interpretation is applicable.

    Time frame: At baseline (immediately before incision), and at 1st, 2nd, and 3rd hour intraoperatively

06

Study locations

1 site
  • Antalya Training and Research Hospital
    Antalya, Muratpasa 07100, Turkey (Türkiye)
07

Registry details

Key details

Study ID
NCT07050719
Lead sponsor
Antalya Training and Research Hospital
Responsible party
Nilgun Kavrut Ozturk (PROFESSOR MD, Antalya Training and Research Hospital) — Principal investigator
First posted
Jul 3, 2025
Start date
Jul 15, 2025
Primary completion
Dec 8, 2025
Completion
Dec 8, 2025
Last update
Dec 10, 2025

Study contacts

NILGUN KAVRUT OZTURK, PROFESSOR MD
study chair · Antalya Training and Research Hospital
AYSE MERVE ERDEM, RESIDENT
principal investigator · Antalya Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion